Cargando…

Phenomic technologies in drug discovery of neglected diseases

Detalles Bibliográficos
Autor principal:	Nehrbass, Ulf
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Lecture Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3019398/

Ejemplares similares

Shortening the drug discovery pipeline: small molecule high content screening for lead discovery in neglected disease
por: Cechetto, Jonathan, et al.
Publicado: (2011)

Vaccines for neglected diseases: challenges and opportunities
por: Saul, Allan
Publicado: (2011)

Discovery of nitric oxide and cyclic GMP in cell signaling and their role in drug development
por: Murad, Ferid
Publicado: (2012)

A phenomics approach for antiviral drug discovery
por: Rietdijk, Jonne, et al.
Publicado: (2021)

PhenomeNET: a whole-phenome approach to disease gene discovery
por: Hoehndorf, Robert, et al.
Publicado: (2011)

Phenome-driven disease genetics prediction toward drug discovery
por: Chen, Yang, et al.
Publicado: (2015)

Two steps forward, one step back: successes and failures in structure-based discovery of GPCR ligands
por: Carlsson, Jens
Publicado: (2015)

A genomic approach to biomarker discovery in human autoimmune diseases
por: Pascual, V
Publicado: (2010)

Drug therapy: preparation, administration and disposal
por: Diano, G, et al.
Publicado: (2010)

Prevention of adverse events in the administration of drugs
por: Diano, G, et al.
Publicado: (2010)

Purinergic signalling: from discovery to current developments
por: Burnstock, Geoffrey
Publicado: (2014)

Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery
por: Henry, Jason, et al.
Publicado: (2019)

Purinergic transmission in brain tumors and its impact on drug development
por: Abbracchio, Maria, et al.
Publicado: (2015)

Signal Transduction: An Exciting Field of Investigation for Small Molecule Drug Discovery
por: Halazy, Serge
Publicado: (2003)

Phenome-based gene discovery provides information about Parkinson’s disease drug targets
por: Chen, Yang, et al.
Publicado: (2016)

HLA guided epitope discovery in Type 1 diabetes to generate novel therapeutics
por: Peakman, M
Publicado: (2010)

Logopedics management in neurovascular diseases
por: Mazzeo, R
Publicado: (2010)

Nodular thyroid disease in the erderly
por: Belfiore, A
Publicado: (2010)

Pharmacological treatment of Parkinson’s disease
por: Arabia, G
Publicado: (2010)

Molecular pathways to Parkinson’s disease
por: Guo, Ming
Publicado: (2012)

The oligodendroglia cytoskeleton in health and disease
por: Richter-Landsberg, Christiane
Publicado: (2015)

Osteoarthicular diseases in the elderly: the challenge of rehabilitation
por: Iocco, M
Publicado: (2010)

Endovascular treatment in peripheral arterial disease
por: Conti, A, et al.
Publicado: (2010)

Functional neurosurgery in Parkinson's disease therapy
por: Lavano, A
Publicado: (2010)

Laboratory diagnostics in the elderly: cardiovascular disease
por: Sciacqua, A, et al.
Publicado: (2010)

The roles of fractalkine signaling in neurodegenerative disease
por: Lamb, Bruce
Publicado: (2012)

Presenilins in Alzheimer’s disease and frontotemporal dementia
por: Shen, Jie
Publicado: (2012)

Osteoporosis: a 3rd millennium disease
por: Ippolito, E, et al.
Publicado: (2010)

The protein quality control system in motoneuron diseases
por: Poletti, Angelo, et al.
Publicado: (2015)

MicroRNA-target interactions in neurodegenerative diseases
por: Soreq, Hermona
Publicado: (2015)

Does axonopathy play a role in Parkinson's disease?
por: O’Malley, Karen L, et al.
Publicado: (2012)

Novel circuitry and molecular pathogenic mechanisms in Huntington's disease
por: Yang, X William
Publicado: (2012)

Autism as a disease of the synapse: search for mechanistic insight
por: Ehrenreich, Hannelore
Publicado: (2015)

Elucidating the mechanisms underlying Alzheimer's disease-associated genetic polymorphisms
por: Estus, Steven
Publicado: (2012)

BACE1, the Alzheimer's beta-secretase enzyme, in health and disease
por: Vassar, Robert
Publicado: (2012)

Mechanisms of mitochondrial quality control in autosomal recessive Parkinson’s disease
por: Corti, Olga
Publicado: (2015)

Discovery of Drug-Responsive Phenomic Alteration-Related Driver Genes in the Treatment of Coronary Heart Disease
por: Guan, Shuang, et al.
Publicado: (2023)

Buruli ulcer disease: challenges and opportunities for Institut Pasteur International Network
por: Eyangoh, Sara
Publicado: (2011)

Recent developments in tau-based therapeutics for Alzheimer’s disease and related dementsia
por: Medina, Miguel
Publicado: (2015)

Activity-dependent neuroprotective protein (ADNP): from autism to Alzheimer’s disease
por: Gozes, Illana
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rnqc5851pc2gcqnf4dpgeger5b